Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53

Mack, David H., Vartikar, Jai, Pipas, James M., Laimins, Laimonis A.·1993·Nature
DOI 10.1038/363281a0

Cited by (322)

Items 201–300 of 322

  1. Inactive p53 mutants may enhance the transcriptional activity of wild-type p53.
    Wei Zhang, Jerry W. Shay, Albert Deisseroth · 1993 · PubMed
  2. Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression
    Jian-Shen Qi, Vandana Desai-Yajnik, Yaping Yuan, Herbert H. Samuels · 1997 · Molecular and Cellular Biology
  3. Adenovirus-mediated p53 tumor suppressor gene therapy of osteosarcoma
    Vladimir V. Ternovoi, David T. Curiel, Bruce Frederic Smith, Gene P. Siegal · 2006 · Laboratory Investigation
  4. p53 Acts as a Co-Repressor to Regulate Keratin 14 Expression during Epidermal Cell Differentiation
    Bi‐He Cai, Pei-Ching Hsu, I‐Lun Hsin, Chung‐Faye Chao, Meihua Lu, Hwang-Chi Lin, Shih‐Hwa Chiou, Pao‐Luh Tao, Jang-Yi Chen · 2012 · PLoS ONE
  5. P53 Activates Fanconi Anemia Group C Gene Expression
    Wolfgang Liebetrau, A. Budde, Anna Savoia, Friedrich Grummt, Holger Hoehn · 1997 · Human Molecular Genetics
  6. Factors related to enrollment in the breast cancer prevention trial at a comprehensive cancer center during the first year of recruitment
    Anita Yeomans Kinney, Sally W. Vernon, Ralph F. Frankowski, Diane M. Weber, Joann M. Bitsura, Victor G. Vogel · 1995 · Cancer
  7. Several regions of p53 are involved in repression of RNA polymerase III transcription
    Torsten Stein, Diane Crighton, Lorna Jane Warnock, Jo Milner, Robert J. White · 2002 · Oncogene
  8. P53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer
    Ravinder Dahiya, G Deng, K.S. Chen, Richard M. Chui, Peter C. Haughney, Perinchery A. Narayan · 1996 · British Journal of Cancer
  9. Transcriptional Regulation by p53
    Yu-Shen Hsu, Fen-Mei Tang, Weili Liu, Jing‐Yuan Chuang, Ming–Yang Lai, Young-Sun Lin · 1995 · Journal of Biological Chemistry
  10. An immunohistochemical study of p53 and proliferating cell nuclear antigen expression in progressive multifocal leukoencephalopathy
    G. Alistair Lammie, A. A. J. Beckett, Robert J. Courtney, Francesco Scaravilli · 1994 · Acta Neuropathologica
  11. Stimulation of Polyomavirus DNA Replication by Wild-Type p53 Through the DNA-Binding Site
    Teru Kanda, K Segawa, Noriaki Ohuchi, Satoshi Mori, Yoshiaki Ito · 1994 · Molecular and Cellular Biology
  12. Immunobiology of Gliomas: New Perspectives for Therapy
    Pierre‐Yves Dietrich, Paul R. Walker, Philippe Saas, Nicolas de Tribolet · 1997 · Annals of the New York Academy of Sciences
  13. Targeting gene expression to tumor cells with loss of wild-type p53 function
    Jingde Zhu, Baomei Gao, Jiangqin Zhao, Allan Balmain · 2000 · Cancer Gene Therapy
  14. Integration of the PRB and P53 Cell Cycle Control Pathways
    Craig L. Stewart, Alejandro Moro Soria, Paul A. Hamel · 2001 · Journal of Neuro-Oncology
  15. Liver-specific Enhancer II Is the Target for the p53-mediated Inhibition of Hepatitis B Viral Gene Expression
    Hyun‐Sook Lee, Hong Tae Kim, Yungdae Yun · 1998 · Journal of Biological Chemistry
  16. p53 and the CNS
    Giulia Fulci, Erwin G. Van Meir · 1999 · Molecular Neurobiology
  17. p53 suppresses cytokine induced, Stat5 mediated activation of transcription
    Michael Fritsche, Maren Mundt, Christian Merkle, Ruth Jähne, Bernd Groner · 1998 · Molecular and Cellular Endocrinology
  18. Predictive value of p53 mutations analyzed in bladder washings for progression of high-risk superficial bladder cancer.
    Jacqueline A. M. Vet, J.A. Witjes, Salvatore A. E. Marras, Daphne Hessels, Henk G. van der Poel, Frans M.J. Debruyne, Jack A. Schalken · 1996 · PubMed
  19. The transcriptional activity of HERV-I LTR is negatively regulated by its cis-elements and wild type p53 tumor suppressor protein
    Nien-Tzu Chang, Wen Yang, Huey-Chung Huang, Kai‐Wun Yeh, Cheng-Wen Wu · 2006 · Journal of Biomedical Science
  20. Expression of cyclooxygenase-2 in colorectal adenocarcinoma is associated with p53 accumulation and hdm2 overexpression
    Ratchada Cressey, Sarunya Pimpa, Waragorn Tontrong, Onusa Wattananupong, Nirush Leartprasertsuke · 2005 · Cancer Letters
  21. Discerning the function of p53 by examining its molecular interactions
    Jonathan D. Oliner · 1993 · BioEssays
  22. Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53
    Yu Wu, Hua Huang, Zoe Miner, Molly F Kulesz-Martin · 1997 · Proceedings of the National Academy of Sciences
  23. Mechanisms of Action of the p53 Tumor Suppressor and Prospects for Cancer Gene Therapy by Reconstitution of p53 Function
    Klaus Roemer, Theodore Friedmann · 1994 · Annals of the New York Academy of Sciences
  24. Modulation of Interleukin-6-induced Plasma Protein Secretion in Hepatoma Cells by p53 Species
    Ling Wang, Ravi J. Rayanade, Dorys García, Kirit Patel, Heng Pan, Pravin B. Sehgal · 1995 · Journal of Biological Chemistry
  25. Mdm2 inhibition of p53 induces E2F1 transactivation via p21
    Mark Wunderlich, Steven J. Berberich · 2002 · Oncogene
  26. Use of Semiquantitative Reverse Transcription-polymerase Chain Reaction to Study Gene Expression in Normal Human Skin Fibroblasts Following Low Dose-rate Irradiation
    S.M. de Toledo, Edouard I. Azzam, M.K. Gasmann, R. E. J. Mitchel · 1995 · International Journal of Radiation Biology
  27. Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene
    Vassilis G. Gorgoulis, Panayiotis Zacharatos, E N Manolis, John Ikonomopoulos, Alexander Damalas, C Lamprinopoulos, George Z. Rassidakis, Vassilis C. Zoumpourlis, Athanassios Kotsinas, A Rassidakis et al. · 1998 · British Journal of Cancer
  28. Tumor Suppressor p53 Down‐Regulates Tissue‐Specific Expression of Tyrosinase Gene in Human Melanoma Cell Lines
    Julia V. Kichina, Albert Green, Sikha Rauth · 1996 · Pigment Cell Research
  29. The Phosphotyrosyl Phosphatase Activator Gene Is a Novel p53 Target Gene
    Veerle Janssens, Christine VAN HOOF, Ivo DE BAERE, Wilfried J. Merlevede, Jozef Goris · 2000 · Journal of Biological Chemistry
  30. Promoter Structure-dependent Functioning of the General Transcription Factor IIE in Saccharomyces cerevisiae
    Hiroshi Sakurai, Tomoko Ohishi, Toshio Fukasawa · 1997 · Journal of Biological Chemistry
  31. The MDM2–p53 pathway: multiple roles in kidney development
    Samir Sayem El-Dahr, Sylvia A. Hilliard, Karam Aboudehen, Zubaida R. Saifudeen · 2013 · Pediatric Nephrology
  32. Identification of Elements Essential for Transcription in Brugia malayi Promoters
    Tarig B. Higazi, Ana de Oliveira, Charles R. Katholi, Limin Shu, Joseph Barchue, Mark Lisanby, Thomas Raymond Unnasch · 2005 · Journal of Molecular Biology
  33. Systemic gene therapy with p53 inhibits breast cancer recent advances and therapeutic implications
    Archibald James Mixson · 1998 · Frontiers in bioscience
  34. Modulation of transcriptional activation of the proliferating cell nuclear antigen promoter by the adenovirus E1A 243-residue oncoprotein depends on proximal activators
    Gilbert F. Morris, Claude Labrie, Michael B. Mathews · 1994 · Molecular and Cellular Biology
  35. P53 tumour suppressor modulates transcription of the TATA-less gene coding for the tumour-associated carbonic anhydrase MN/CA IX in MaTu cells
    Milota Kaluzová, Silvia Pastoreková, Jaromı́r Pastorek, Štefan Kaluz · 2000 · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
  36. Repression of the minimal hla-b promoter by c-myc and p53 occurs through independent mechanisms
    Marieke Griffioen, Wilma T. Steegenga, Ilse J.M. Ouwerkerk, Lucy T.C. Peltenburg, Aart G. Jochemsen, Peter I. Schrier · 1998 · Molecular Immunology
  37. Repression of Transcription From the Human T-Cell Leukemia Virus Type I Long Terminal Repeat and Cellular Gene Promoters by Wild-Type p53
    Naoki Mori, Fatah Kashanchi, Diane Prager · 1997 · Blood
  38. Functions of pRb and p53: what's the connection?
    Tony Kouzarides · 1995 · Trends in Cell Biology
  39. Studies on modulation of the activity of tumor suppressor protein p53
    Lilian Kadaja · 2004 · DSpace repository (University of Tartu)
  40. A novel carbonic anhydrase II mRNA isolated from mature chicken testis displays a TATA box and other promoter sequences in a leader 5′ untranslated region not present in somatic tissues
    Jovita Mezquita, Montserrat Pau, Cristóbal Mezquita · 1994 · Gene
  41. Novel transcripts of carbonic anhydrase II in mouse and human testis
    Pau Mezquita · 1999 · Molecular Human Reproduction
  42. p53 Amino Acids 339–346 Represent the Minimal p53 Repression Domain
    Tse-Ming Hong, Jeremy J.W. Chen, Konan Peck, Pan‐Chyr Yang, Cheng‐Wen Wu · 2001 · Journal of Biological Chemistry
  43. Down-regulation of Rous sarcoma virus long terminal repeat promoter activity by a HeLa cell basic protein.
    C H Yeh, Aaron J. Shatkin · 1994 · Proceedings of the National Academy of Sciences
  44. Regulation of parathyroid hormone-related protein gene expression in murine keratinocytes by E1A isoforms: a role for basal promoter and Ets-1 site
    John Foley, John J. Wysolmerski, Caterina Missero, Connie S King, William M. Philbrick · 1999 · Molecular and Cellular Endocrinology
  45. Transcription of the Rat p53 Gene Is Mediated by Factor Binding to Two Recognition Motifs of NF1-Like Protein
    Minhyung Lee, Haisun Song, Sunhee Park, Jong-sang Park · 1998 · Biological Chemistry
  46. The p53 Tumor Suppressor Gene: Structure, Function and Mechanism of Action
    Caroline Choisy, Philippe Reisdorf, Elisheva Yonish-Rouach · 1999 · Results and problems in cell differentiation
  47. Protein p53 Modulates Transcription from a Promoter Containing its Binding Site in a Concentration‐Dependent Manner
    Arnold Kristjuhan, Toivo Maimets · 1995 · European Journal of Biochemistry
  48. A Spectrum of Mechanisms for the Assembly of the RNA Polymerase II Transcription Preinitiation Complex
    Catherine P. George, Lucy M. Lira, Sharon L. Wampler, James T. Kadonaga · 1995 · Molecular and Cellular Biology
  49. Inhibitory Effects and Mechanism of the Natural Compound Diaporthein B Extracted from Marine-Derived Fungi on Colon Cancer Cells
    Peihua Tang, Dandan Liu, Zheli Wu, Hui Cui, Ren Zhang, Zaoyuan Kuang · 2022 · Molecules
  50. Characterization of rare p53 mutants from carcinogen-treated albumin-simian virus 40 T-antigen transgenic rats.
    Michael John Haas, Henry Clement Pitot · 1998 · PubMed
  51. A Role for TAF3B2 in the Repression of Human RNA Polymerase III Transcription in Nonproliferating Cells
    Knut Eichhorn, Stephen P. Jackson · 2001 · Journal of Biological Chemistry
  52. Functional interaction between cyclooxygenase-2 and p53 in response to an endogenous electrophile
    Takeshi Kumagai, Hiroko Usami, Nao Matsukawa, Fumie Nakashima, Miho Chikazawa, Takahiro Shibata, Noriko Noguchi, Kôji Uchida · 2014 · Redox Biology
  53. Effects of p53 or p27 overexpression on cyclooxygenase‐2 gene expression in head and neck squamous cell carcinoma cell lines
    Dong Wook Lee, Seokwoo Park, Soo‐Yeun Park, Dae‐Seog Heo, Kwang Hyun Kim, Myung‐Whun Sung · 2004 · Head & Neck
  54. Identification and Characterization of Genes Whose Expressions Are Altered in Rat 6 Fibroblasts Transformed by Mutant p53val135
    Judy Wai Ping Yam, Jian Zheng, Wen Luan Wendy Hsiao · 1999 · Biochemical and Biophysical Research Communications
  55. Cancer genetics
    Luisa Lanfrancone, Giuliana Pelicci, Pier Giuseppe Pelicci · 1994 · Current Opinion in Genetics & Development
  56. A novel pathological role of p53 in kidney development revealed by gene-environment interactions
    Hao Fan, Jessica R. Harrell, Susana Dipp, Zubaida R. Saifudeen, Samir Sayem El-Dahr · 2004 · American Journal of Physiology-Renal Physiology
  57. Tumor suppressor genes in molecular medicine
    Felix Hoppe‐Seyler, Karin Butz · 1994 · Journal of Molecular Medicine
  58. Regulation of scatter factor (hepatocyte growth factor) production by tumor-stroma interaction
    Eliot M. Rosen, I D Goldberg · 1995 · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions
  59. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas
    Bruce Ruggeri, Lingyi Huang, Moira Wood, Jin Quan Cheng, Joseph R. Testa · 1998 · Molecular Carcinogenesis
  60. Genomic Organization and Chromosomal Mapping of the Bovine Fas/APO-1 Gene
    Jakyoung Yoo, ROGER T. STONE, Steve M. Kappes, S. Solinas Toldo, Ruedi Fries, Craig W. Beattie · 1996 · DNA and Cell Biology
  61. miR‑181b‑p53 negative feedback axis regulates osteosarcoma cell proliferation and invasion
    Jun Wan, Feng Long, Can Zhang, Yupeng Liu · 2020 · International Journal of Molecular Medicine
  62. Quantification of p53 expression in the nervous system
    Gary Weisinger, Y Tendler, Oren Zinder · 2000 · Brain Research Protocols
  63. Immunobiology of malignant gliomas
    Mitsuhiro Tada, Nicolas de Tribolet · 1996 · Journal of Clinical Neuroscience
  64. Recessive oncogenes: Current status
    Xiang Gao, Kenneth V. Honn · 1995 · Pathology & Oncology Research
  65. High Throughput miRNA Screening Identifies miR-574-3p Hyperproductive Effect in CHO Cells
    Živa Švab, Luca Braga, Corrado Guarnaccia, Ivan Labik, Jeremias S. Herzog, Marco Baralle, Mauro Giacca, Nataša Skoko · 2021 · Biomolecules
  66. Pathways of p53-Dependent Apoptosis
    Luigi Grasso, W. Edward Mercer · 1997 · Vitamins and hormones
  67. p53-dependent and -independent transactivation by the E6 protein of human papillomavirus type 16
    Naotake Akutsu, Hiroshi Shirasawa, T. Asano, K Isono, B. Simizu · 1996 · Journal of General Virology
  68. Prognostic and predictive value of p53 and p21 in breast cancer
    Richard M. Elledge, Donald Craig Allred · 1998 · Springer eBooks
  69. Dominant‐negative p53 can restore tumorigenicity of L‐929 cells in immunocompetent mice
    Leonard Joseph Appleman, Alan B. Frey · 1995 · International Journal of Cancer
  70. Wild Type p53 Activity Contributes to Dependence on Hematopoietic Survival Factors
    Eyal Gottlieb, Rebecca Haffner, Elisheva Yonish-Rouach, Thomas von Rüden, Erwin Friedrich Wagner, Moshe Oren · 1994 · Springer eBooks
  71. Effects of Uwhangchungsimwon on Cell Viability, Proliferation, and Gene Expression of Human Neuronal Cell line IMR32
    Keun Song, Young-Suk Kim, Sang‐Kwan Moon, Chang‐Nam Ko, Ki‐Ho Cho, Hyung-Sup Bae, Kyung-Sup Lee · 2001 · The American Journal of Chinese Medicine
  72. Posttranslational Mechanisms Leading to Mammalian Gene Activation in Response to Genotoxic Stress
    Liu Y, Myriam Gorospe, Nikki J. Holbrook, Carl W. Anderson · 1998 · Humana Press eBooks
  73. Constitutive and DNA Damage Inducible Activation of pig3 and MDM2 Genes by Tumor-Derived p53 Mutant C277Y
    Šárka Pospı́šilová, Christine Siligan, Jozet Ban, Gunhild Jug, Heinrich Kovar · 2004 · Molecular Cancer Research
  74. Cytokine Expression and Signaling in Brain Tumors
    Erwin G. Van Meir, Nandini Dey, Donald L. Durden · 2005 · CRC Press eBooks
  75. Repression of Transcription and Interference with DNA Binding of TATA-Binding Protein by C-Terminal Alternatively Spliced p53
    Huayi Huang · 2002 · Experimental Cell Research
  76. Transcription stimulation of the adenovirus type 12 E1a gene in vitro by the 266-amino-acid E1A protein
    H Kawamura, N Wada, Y Makino, T A Tamura, S Koikeda, Kazuko Shiroki, Yukito Masamune, Yoshinobu Nakanishi · 1994 · Journal of Virology
  77. Overproduced p73α activates a minimal promoter through a mechanism independent of its transcriptional activity
    Shinji Takagi, Yoshihide Ueda, Makoto Hijikata, Kunitada Shimotohno · 2001 · FEBS Letters
  78. Initiator-dependent transcription in vitro by a wheat germ chromatin extract
    Patrick Schweizer, Egon M�singer · 1994 · Plant Molecular Biology
  79. Photoprotektive Mechanismen in menschlicher Haut Modulation durch Oligonukleotide
    Ina Hadshiew, Mark S. Eller, Ingrid Moll, Barbara A. Gilchrest · 2002 · Der Hautarzt
  80. Germ-line deletion of p53 reveals a multistage tumor progression in spi-1/PU.1 transgenic proerythroblasts
    Erwan Le Scolan, Françoise Wendling, Stéphane Barnache, Nicole Denis, Micheline Tulliez, William Vainchenker, Françoise Moreau-Gachelin · 2001 · Oncogene
  81. Effects of chromosomal integration site upon p53 interactions with DNA consensus sequence homologies
    Julia L. Cook, Z Zhang, J Alam, Richard N. Ré · 1999 · Oncogene
  82. p22/PACAP Response Gene 1 (PRG1): A Putative Target Gene for the Tumor Suppressor p53
    H. Schäfer, Anna Trauzold, Thorsten Sebens, Wolfgang Deppert, Ulrich Robert Fölsch, Wolfgang Ekkehard Schmidt · 1998 · Annals of the New York Academy of Sciences
  83. Absence of p53 mutation in Japanese patients with malignant thyroid lymphoma
    KOICHIRO IYOTA, Kyoko Takeda, Fumio Matsuzuka, Takehiro Okabayashi, S. Morita, Kanji Kuma, Kozo Hashimoto · 1994 · Journal of Endocrinological Investigation
  84. TRANSCRIPTIONAL CONTROL AND THE REGULATION OF ENDOCRINE GENES
    Jeffrey D. Zajac, Peter J. Chilco · 1995 · Clinical and Experimental Pharmacology and Physiology
  85. p53 Modulation of DNA Topoisomerase IIα Gene Expression
    Ashish A. Joshi, Qingjian Wang, D. Parker Suttle · 2000 · Cell Biochemistry and Biophysics
  86. p53 protein activates the transcription of human proliferating cell nuclear antigen in response to 4-nitroquinoline N-oxide treatment
    Yuanyuan Li, Lei Wang, Shihua Li, Ting-Qing Guo, Xiuyang Guo, Peijun Yan, Ying Chen, Lingzhi Wang, Chang‐De Lu · 2004 · The International Journal of Biochemistry & Cell Biology
  87. Inducible photoprotection in skin: Evidence for a eukaryotic SOS response
    Mark S. Eller, Barbara A. Gilchrest · 2001 · Advances in cell aging and gerontology
  88. Transcriptional regulation of the glial cell-specific JC virus by p53
    Hee-Sun Kim, Moon-Sook Woo · 2002 · Archives of Pharmacal Research
  89. Recent insights into the molecular basis of intrinsic resistance of colorectal cancer: new challenges for systemic therapeutic approaches
    Jean L. Grem · 1998 · Cancer treatment and research
  90. Lymphocyte Death, p53, and the Problem of the “Undead” Cell
    David James Harrison, Sarah Howie, A H Wyllie · 1995 · Current topics in microbiology and immunology
  91. Transcriptional repression in normal human keratinocytes by wild-type and mutant p53
    Luis Marat Álvarez-Salas, Araceli Velazquez, Esther López‐Bayghen, Craig D. Woodworth, Efraí­n Garrido, Patricio Gariglio, Joseph A. DiPaolo · 1995 · Cancer Letters
  92. Cyclooxygenase-2 Gene Expression
    Shrikant Anant, Sripathi M. Sureban · 2007 · Humana Press eBooks
  93. p53: a cellular Achilles' heel revealed
    Stephen Kevin Burley · 1994 · Structure
  94. Promoters for Expression of Gene Products within Neurons and Glia
    J. Henson · 1998 · Humana Press eBooks
  95. Inactivation of Negative Growth Regulators During Neoplastic Transformation
    Kara N. Smolinski, Stephen J. Meltzer · 2002 · Humana Press eBooks
  96. Transcriptional Repression by the p53 Tumor Suppressor Protein
    Jack T. Zilfou, Maureen E. Murphy · 2005 · Springer eBooks
  97. Chapter 5 Molecular biology of prostate cancer
    Xiang Gao, Kenneth V. Honn · 1999 · Advances in oncobiology/Advances in oncobiology (Print)
  98. Scatter Factor As a Potential Tumor Angiogenesis Factor
    Eliot M. Rosen, Itzhak D. Goldberg · 1996 · Springer eBooks
  99. UV Response of Mammalian p53 Tumor Supressor Gene
    Tarja Mälkönen · 1999 · Työväentutkimus Vuosikirja
  100. Oncogenes and Onco‐suppressor Genes in Female Genital Cancer
    Maria D. Koffa, Demetrios A. Spandidos · 1997 · Annals of the New York Academy of Sciences